Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2024-10-23 | Amended | $11,249,998 | $7,000,008 | Equity Only | 06b | SEC link |
2024-06-11 | New | $4,249,990 | $4,249,990 | Equity Only | 06b | SEC link |
2024-03-13 | New | $4,249,989 | $4,249,989 | Equity Only | 06b | SEC link |
2023-06-27 | New | $6,000,000 | $6,000,000 | Equity Only | 06b | SEC link |
2022-12-12 | New | $3,000,159 | $3,000,159 | Equity Only | 06b | SEC link |
2022-10-07 | New | $9,007,812 | $9,007,812 | Equity Only | 06b | SEC link |
2022-08-22 | New | $5,000,319 | $5,000,319 | Equity Only | 06b | SEC link |
2022-07-12 | New | $5,000,319 | $5,000,319 | Equity Only | 06b | SEC link |
2022-05-05 | New | $5,000,000 | $5,000,000 | Debt Only | 06b | SEC link |
2022-03-17 | New | $5,000,319 | $5,000,319 | Equity Only | 06b | SEC link |
2022-01-11 | New | $5,000,159 | $5,000,159 | Equity Only | 06b | SEC link |
2021-10-29 | New | $5,000,159 | $5,000,159 | Equity Only | 06b | SEC link |
2021-08-06 | New | $6,000,000 | Unknown | Equity Only | SEC link | |
2021-06-04 | New | $3,000,159 | Unknown | Equity Only | SEC link | |
2021-06-04 | New | $10,000,000 | Unknown | Equity Only | SEC link | |
2018-10-29 | New | $5,971,142 | $5,971,142 | Equity Only | 06b | SEC link |
2017-08-15 | New | $9,999,522 | $9,999,522 | Equity Only | 06b | SEC link |
2016-09-14 | New | $107,999,363 | $107,999,363 | Equity and Debt | 06b | SEC link |
Name | Role |
---|---|
Shahab N. Abidi | Director |
Syed E. Abidi | Director |
Sana I. Abidi | Director |
Syed E Abidi, Ph.D. | Director |
Michael Bogda | Director |
Jillian Dettinger | Executive |
Gerard Fleury | Executive |
John Fowler | Director, Executive |
James Gale | Director |
John Guthrie | Executive |
Julien Hecht | Executive |
Mark Kavulich | Director |
Joseph Kiely | Executive |
Kurt Nielsen, Ph.D. | Director, Executive |
Shahid Raza | Director |
David Solomon | Director |
George Svokos | Director |
Kevin Walsh | Director |